Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
West China Journal of Stomatology ; (6): 524-530, 2021.
Article in English | WPRIM | ID: wpr-921369

ABSTRACT

OBJECTIVES@#To compare the effects of different irradiators on the establishment of osteoradionecrosis of jaw model (ORNJ) to explore an ideal modeling method.@*METHODS@#A total of 33 adult SD rats were included and randomly divided into three groups according to the radiation equipment, namely, the blank control (CN, 3 rats), group A (linear accelerator irradiation, 15 rats), and group B (small-animal irradiator irradiation, 15 rats). Groups A and B were irradiated with daily fractions of 7, 8, and 9 Gy for 5 days and further divided into three subgroups as follows: group A@*RESULTS@#At 3 weeks after dental extractions, complete gingival healing was found in the regions of dental extractions in groups A@*CONCLUSIONS@#Small-animal irradiator irradiation is an ideal device for establishing ORNJ model.


Subject(s)
Animals , Rats , Mandible , Molar , Osteoradionecrosis/etiology , Rats, Sprague-Dawley , X-Ray Microtomography
2.
Journal of Experimental Hematology ; (6): 245-249, 2016.
Article in Chinese | WPRIM | ID: wpr-272469

ABSTRACT

Although the traditional chemotherapy has achieved a certain effect for patients with acute myeloid leukemia (AML), but there are still limitations in terms of improving the rate of complete remission and overcome relapse after remission. The further study found that many cytogenetic molecular and epigenetic abnormalities occurred during the progression of AML, such as abnormal expression of cell surface molecules, mutation, gene aberrant methylation and so on. The drugs targeted at these changes can improve the prognosis for patients, and provide a new way for treating patients with AML. At present, the mostly targeted drugs include monoclonal antibodies CD33-Ab, tyrosine kinase inhibitor, inhibitors of DNA methyltransferases inhibitors and so on. In this review, the progress of targeted therapy in AML treatment is summarized.


Subject(s)
Humans , Antibodies, Monoclonal , Therapeutic Uses , DNA Modification Methylases , Leukemia, Myeloid, Acute , Drug Therapy , Mutation , Prognosis , Protein Kinase Inhibitors , Therapeutic Uses , Remission Induction
SELECTION OF CITATIONS
SEARCH DETAIL